Last Updated:
Searching
Create account to add to watchlist!

Silver Spike Acquisition Corp II - SPKB

  • Commons

    $9.78

    +0.00%

    SPKB Vol: 8.4K

  • Warrants

    $1.00

    -4.83%

    SPKBW Vol: 11.7K

  • Units

    $10.05

    +0.40%

    SPKBU Vol: 4.2K

Average: 0
Rating Count: 0
You Rated: Not rated

Please log in to rate.

SPAC Stats

Market Cap: 281.2M
Average Volume: 8.6K
52W Range: $9.61 - $10.05
Weekly %: +0.00%
Monthly %: -0.10%
Inst Owners: 48

Info

Target: Searching
Days Since IPO: 269
Unit composition:
Each unit has an offering price of $10.00 and consists of one Class A ordinary share and one-fourth of one redeemable warrant
Trust Size: 25000000.0M

Management

Officers and Directors Upon the effectiveness of the registration statement of which this prospectus forms a part, we expect that our board of directors will consist of five members. Our board of directors is divided into two classes with only one class of directors being elected in each year and each (except for those directors appointed prior to our first annual meeting of shareholders) serving a two-year term. The term of office of the first class of directors will expire at our first annual meeting of shareholders and the term of office of the second class of directors will expire at our second annual meeting of shareholders. We may not hold an annual meeting of shareholders until after we consummate our initial business combination (unless required by Nasdaq). Subject to any other special rights applicable to the shareholders, any vacancies on our board of directors may be filled by the affirmative vote of a majority of the directors present and voting at the meeting of our board or by a majority of the holders of our ordinary shares (or, prior to our initial business combination, holders of our founder shares). Our officers are elected by the board of directors and serve at the discretion of the board of directors, rather than for specific terms of office. Our board of directors is authorized to appoint persons to the offices set forth in our amended and restated memorandum and articles of association as it deems appropriate. Our amended and restated memorandum and articles of association will provide that our officers may consist of a Chairman, a Chief Executive Officer, a President, a Chief Financial Officer, Vice Presidents, a Secretary, Assistant Secretaries, a Treasurer and such other offices as may be determined by the board of directors. Director Independence Nasdaq listing standards require that a majority of our board of directors be independent within one year of our initial public offering. An “independent director” is defined generally as a person other than an officer or employee of the company or its subsidiaries or any other individual having a relationship which in the opinion of the company’s board of directors, would interfere with the director’s exercise of independent judgment in carrying out the responsibilities of a director. Our board of directors has determined that Orrin Devinsky, Richard Goldman and Kenneth Landis are “independent directors” as defined in the Nasdaq listing standards and applicable SEC rules. Our independent directors will have regularly scheduled meetings at which only independent directors are present. Officer and Director Compensation None of our officers or directors have received or, prior to our initial business combination, will receive any cash compensation for services rendered to us. We will pay our sponsor up to $20,000 per month for office space, administrative and support services. Our sponsor, officers and directors, or any of their respective affiliates, will be reimbursed for any out-of-pocket expenses incurred in connection with activities on our behalf such as identifying potential target businesses and performing due diligence on suitable business combinations. In connection with closing of this offering, our sponsor intends to grant sponsor LLC equity interests to our independent director nominees that collectively comprise approximately 1% of the outstanding equity interests in our sponsor. Our audit committee will review on a quarterly basis all payments that were made to our sponsor, officers, directors or our or any of their affiliates. 119 Table of Contents After the completion of our initial business combination, directors or members of our management team who remain with us may be paid consulting, management or other compensation from the combined company. All compensation will be fully disclosed to shareholders, to the extent then known, in the tender offer materials or proxy solicitation materials furnished to our shareholders in connection with a proposed business combination. It is unlikely the amount of such compensation will be known at the time, because the directors of the post-combination business will be responsible for determining executive officer and director compensation. Any compensation to be paid to our officers after the completion of our initial business combination will be determined by a compensation committee constituted solely by independent directors. We are not party to any agreements with our executive officers and directors that provide for benefits upon termination of employment. The existence or terms of any such employment or consulting arrangements may influence our management’s motivation in identifying or selecting a target business, and we do not believe that the ability of our management to remain with us after the completion of our initial business combination should be a determining factor in our decision to proceed with any potential business combination. Committees of the Board of Directors Pursuant to Nasdaq listing rules we will establish three standing committees - an audit committee in compliance with Section 3(a)(58)(A) of the Exchange Act, a compensation committee and a nominating committee, each comprised of independent directors. Under Nasdaq listing rule 5615(b)(1), a company listing in connection with its initial public offering is permitted to phase in its compliance with the independent committee requirements. We do not intend to rely on the phase-in schedules set forth in Nasdaq listing rule 5615(b)(1). Audit Committee Upon the effectiveness of the registration statement of which this prospectus forms a part, we will establish an audit committee of the board of directors. The members of our audit committee will be Orrin Devinsky, Richard Goldman and Kenneth Landis. Kenneth Landis will serve as chairman of the audit committee. Each member of the audit committee is financially literate and our board of directors has determined that qualifies as an “audit committee financial expert” as defined in applicable SEC rules and has accounting or related financial management expertise. We will adopt an audit committee charter, which will detail the purpose and principal functions of the audit committee, including: ·assisting board oversight of (1) the integrity of our financial statements, (2) our compliance with legal and regulatory requirements, (3) our independent auditor’s qualifications and independence and (4) the performance of our internal audit function and independent auditors; ·the appointment, compensation, retention, replacement and oversight of the work of the independent auditors and any other independent registered public accounting firm engaged by us; ·pre-approving all audit and non-audit services to be provided by the independent auditors or any other registered public accounting firm engaged by us and establishing pre-approval policies and procedures; ·reviewing and discussing with the independent auditors all relationships the auditors have with us in order to evaluate their continued independence; ·setting clear hiring policies for employees or former employees of the independent auditors; ·setting clear policies for audit partner rotation in compliance with applicable laws and regulations; ·obtaining and reviewing a report, at least annually, from the independent auditors describing (1) the independent auditor’s internal quality-control procedures and (2) any material issues raised by the most recent internal quality-control review, or peer review, of the audit firm, or by any inquiry or investigation by governmental or professional authorities, within the preceding five years respecting one or more independent audits carried out by the firm and any steps taken to deal with such issues; 120 Table of Contents ·meeting to review and discuss our annual audited financial statements and quarterly financial statements with management and the independent auditor, including reviewing our specific disclosures under “Management’s Discussion and Analysis of Financial Condition and Results of Operations”; ·reviewing and approving any related party transaction required to be disclosed pursuant to Item 404 of Regulation S-K promulgated by the SEC prior to us entering into such transaction; and ·reviewing with management, the independent auditors, and our legal advisors, as appropriate, any legal, regulatory or compliance matters, including any correspondence with regulators or government agencies and any employee complaints or published reports that raise material issues regarding our financial statements or accounting policies and any significant changes in accounting standards or rules promulgated by the Financial Accounting Standards Board, the SEC or other regulatory authorities. Compensation Committee Upon the effectiveness of the registration statement of which this prospectus forms a part, we will establish a compensation committee of the board of directors. The members of our Compensation Committee will be Orrin Devinsky, Richard Goldman and Kenneth Landis. Richard Goldman will serve as chairman of the compensation committee. We will adopt a compensation committee charter, which will detail the purpose and responsibility of the compensation committee, including: ·reviewing and approving on an annual basis the corporate goals and objectives relevant to our Chief Executive Officer’s compensation, evaluating our Chief Executive Officer’s performance in light of such goals and objectives and determining and approving the remuneration (if any) of our Chief Executive Officer based on such evaluation; ·reviewing and making recommendations to our board of directors with respect to the compensation and any incentive-compensation and equity-based plans that are subject to board approval of all of our other officers; ·reviewing our executive compensation policies and plans; ·implementing and administering our incentive compensation equity-based remuneration plans; ·assisting management in complying with our proxy statement and annual report disclosure requirements; ·approving all special perquisites, special cash payments and other special compensation and benefit arrangements for our officers and employees; ·producing a report on executive compensation to be included in our annual proxy statement; and ·reviewing, evaluating and recommending changes, if appropriate, to the remuneration for directors. The charter will also provide that the compensation committee may, in its sole discretion, retain or obtain the advice of a compensation consultant, independent legal counsel or other adviser and will be directly responsible for the appointment, compensation and oversight of the work of any such adviser. However, before engaging or receiving advice from a compensation consultant, external legal counsel or any other adviser, the compensation committee will consider the independence of each such adviser, including the factors required by Nasdaq and the SEC. Nominating Committee Upon the effectiveness of the registration statement of which this prospectus forms a part, we will establish a nominating committee of the board of directors. The members of our nominating committee will be Orrin Devinsky, Richard Goldman and Kenneth Landis. Orrin Devinsky will serve as chair of the nominating committee. We will adopt a nominating committee charter, which will detail the purpose and responsibilities of the nominating committee, including: ·identifying, screening and reviewing individuals qualified to serve as directors, consistent with criteria approved by the board, and recommending to the board of directors candidates for nomination for election at the annual meeting of shareholders or to fill vacancies on the board of directors; 121 Table of Contents ·developing and recommending to the board of directors and overseeing implementation of our corporate governance guidelines; ·coordinating and overseeing the annual self-evaluation of the board of directors, its committees, individual directors and management in the governance of the company; and ·reviewing on a regular basis our overall corporate governance and recommending improvements as and when necessary. The charter will also provide that the nominating committee may, in their sole discretion, retain or obtain the advice of, and terminate, any search firm to be used to identify director candidates, and will be directly responsible for approving the search firm’s fees and other retention terms. We have not formally established any specific, minimum qualifications that must be met or skills that are necessary for directors to possess. In general, in identifying and evaluating nominees for director, the board of directors considers educational background, diversity of professional experience, knowledge of our business, integrity, professional reputation, independence, wisdom, and the ability to represent the best interests of our shareholders. Compensation Committee Interlocks and Insider Participation None of our officers currently serves, and in the past year has not served, as a member of the board of directors or compensation committee of any entity that has one or more officers serving on our board of directors. Code of Ethics Prior to the effectiveness of the registration statement of which this prospectus is a part, we will have adopted a code of ethics applicable to our directors, officers and employees (our “Code of Ethics”). Our Code of Ethics will be available on our website upon the completion of this offering. Our Code of Ethics is a “code of ethics,” as defined in Item 406(b) of Regulation S-K. We will make any legally required disclosures regarding amendments to, or waivers of, provisions of our Code of Ethics on our website. Conflicts of Interest All of our executive officers and certain of our directors have or may have fiduciary and contractual duties to certain companies in which they have invested. These entities may compete with us for acquisition opportunities. If these entities decide to pursue any such opportunity, we may be precluded from pursuing it. However, we do not expect these duties to present a significant conflict of interest with our search for an initial business combination. Under Cayman Islands law, directors and officers owe the following fiduciary duties: ·duty to act in good faith in what the director or officer believes to be in the best interests of the company as a whole; ·duty to exercise authority for the purpose for which it is conferred; ·duty to not improperly fetter the exercise of future discretion; ·duty not to put themselves in a position in which there is a conflict between their duty to the company and their personal interests; and ·duty to exercise independent judgment. In addition to the above, directors also owe a duty of care, which is not fiduciary in nature. This duty has been defined as a requirement to act as a reasonably diligent person having both the general knowledge, skill and experience that may reasonably be expected of a person carrying out the same functions as are carried out by that director in relation to the company and the general knowledge, skill and experience which that director has. As set out above, directors have a duty not to put themselves in a position of conflict and this includes a duty not to engage in self-dealing, or to otherwise benefit as a result of their position at the expense of the company. However, in some instances what would otherwise be a breach of this duty can be forgiven and/or authorized in advance by the shareholders; provided that there is full disclosure by the directors. This can be done by way of permission granted in the amended and restated memorandum and articles of association or alternatively by shareholder approval at general meetings. 122 Table of Contents Certain of our officers and directors presently have, and any of them in the future may have additional, fiduciary or contractual obligations to other entities pursuant to which such officer or director is or will be required to present a business combination opportunity to such entity. Accordingly, if any of our officers or directors becomes aware of a business combination opportunity that is suitable for an entity to which he or she has then-current fiduciary or contractual obligations, he or she may need to honor these fiduciary or contractual obligations to present such business combination opportunity to such entity, subject to their fiduciary duties under Cayman Islands law. We do not believe, however, that the fiduciary duties or contractual obligations of our officers or directors will materially affect our ability to complete our initial business combination. Our sponsor, officers, directors and Silver Spike Capital may participate in the formation of, or become an officer or director of, any other blank check company prior to completion of our initial business combination. As a result, our sponsor, officers, directors and Silver Spike Capital could have conflicts of interest in determining whether to present business combination opportunities to us or to any other blank check company with which they are or may become involved. In particular, our officers, directors and Silver Spike Capital have formed and are actively engaged in Silver Spike Acquisition Corp., a special purpose acquisition corporation that completed its initial public offering in August 2019 and that has announced a proposed initial business combination with WM Holding Company, LLC. The transaction is subject to approval of Silver Spike Acquisition Corp.’s shareholders and other customer closing conditions. Any such companies may present additional conflicts of interest in pursuing an acquisition target. Potential investors should also be aware of the following potential conflicts of interest: ·None of our officers or directors is required to commit his or her full time to our affairs and, accordingly, may have conflicts of interest in allocating his or her time among various business activities. ·In the course of their other business activities, our officers and directors may become aware of investment and business opportunities that may be appropriate for presentation to us as well as the other entities with which they are affiliated. Our management may have conflicts of interest in determining to which entity a particular business opportunity should be presented. For a complete description of our management’s other affiliations, see “—Directors, Director Nominees and Executive Officers.” ·Our initial shareholders have agreed to waive their redemption rights with respect to their founder shares and any public shares held by them in connection with the completion of our initial business combination. Our directors and officers have also entered into the letter agreement, imposing similar obligations on them with respect to public shares acquired by them, if any. Additionally, our initial shareholders have agreed to waive their redemption rights with respect to their founder shares if we fail to consummate our initial business combination within 24 months after the closing of this offering or during any Extension Period. However, if our initial shareholders or any of our officers, directors or affiliates acquire public shares in or after this offering, they will be entitled to liquidating distributions from the trust account with respect to such public shares if we fail to consummate our initial business combination within the prescribed time frame. If we do not complete our initial business combination within such applicable time period, the proceeds of the sale of the private placement warrants held in the trust account will be used to fund the redemption of our public shares, and the private placement warrants will expire worthless. With ce

Holder Stats

1 0
% of Shares Held by All Insider 6.61%
% of Shares Held by Institutions 73.43%
% of Float Held by Institutions 78.62%
Number of Institutions Holding Shares 48

Mutual Fund Holders

Holder Shares Date Reported Value % Out
Collaborative Inv Ser Tr-SPAC and New Issue ETF 196939 2021-06-29 1920155 0.69
Fidelity NASDAQ Composite Index Fund 5656 2021-08-30 54580 0.02

Institutional Holders

Reporting Date Hedge Fund Shares Held Market Value % of Portfolio Quarterly Change in Shares Ownership in Company
2021-11-17 Centiva Capital LP 80,094 $790,000 0.0% -43.6% 0.952%
2021-11-16 Wellington Management Group LLP 344,732 $3,380,000 0.0% 0 4.098%
2021-11-16 Citadel Advisors LLC 2,365,935 $23,190,000 0.0% +238.0% 28.126%
2021-11-16 CNH Partners LLC 100,000 $980,000 0.0% 0 1.189%
2021-11-16 Centiva Capital LP 80,094 $790,000 0.0% -43.6% 0.952%
2021-11-15 Rivernorth Capital Management LLC 24,996 $250,000 0.0% 0 0.297%
2021-11-15 Marshall Wace LLP 366,702 $3,590,000 0.0% 0 4.359%
2021-11-15 Royal Bank of Canada 48,991 $480,000 0.0% 0 0.582%
2021-11-15 Glazer Capital LLC 317,816 $3,120,000 0.1% +242,507.6% 3.778%
2021-11-15 Highbridge Capital Management LLC 1,397,845 $13,700,000 0.4% +9.4% 16.617%
2021-11-12 GABELLI & Co INVESTMENT ADVISERS INC. 74,329 $730,000 0.1% 0 0.884%
2021-11-12 Senvest Management LLC 941,296 $9,230,000 0.3% +0.1% 11.190%
2021-11-12 Gabelli Funds LLC 78,577 $770,000 0.0% 0 0.934%
2021-11-12 Periscope Capital Inc. 499,800 $4,900,000 0.1% 0 5.942%
2021-11-12 Macquarie Group Ltd. 562,500 $5,510,000 0.0% 0 6.687%
2021-11-12 Cohanzick Management LLC 5,510 $54,000 0.0% 0 0.066%
2021-11-12 CI Investments Inc. 17,000 $170,000 0.0% 0 0.202%
2021-10-25 Exos Asset Management LLC 115,646 $1,130,000 0.6% +14.0% 1.375%
2021-10-22 Tuttle Capital Management LLC 189,182 $1,480,000 0.7% -23.4% 2.249%
2021-09-10 HBK Investments L P 400,000 $3,900,000 0.0% 0 4.755%
2021-08-20 Jefferies Group LLC 120,000 $1,170,000 0.0% 0 1.427%
2021-08-17 Citadel Advisors LLC 700,000 $6,830,000 0.0% 0 8.321%
2021-08-16 Whitebox Advisors LLC 50,000 $490,000 0.0% 0 0.594%
2021-08-16 LMR Partners LLP 50,000 $490,000 0.0% 0 0.594%
2021-08-16 Berkley W R Corp 49,124 $480,000 0.0% 0 0.584%
2021-08-16 Telemetry Investments L.L.C. 280,000 $2,730,000 3.8% 0 3.329%
2021-08-16 Jefferies Group LLC 120,000 $1,170,000 0.0% 0 1.427%
2021-08-16 Polygon Management Ltd. 530,200 $5,170,000 0.3% 0 6.303%
2021-08-16 HBK Investments L P 400,000 $3,900,000 0.0% 0 4.755%
2021-08-16 Linden Advisors LP 1,272,744 $12,410,000 0.1% 0 15.130%
2021-08-16 Radcliffe Capital Management L.P. 300,000 $2,930,000 0.1% 0 3.566%
2021-08-13 Ancora Advisors LLC 5,000 $49,000 0.0% 0 0.059%
2021-08-13 Senvest Management LLC 939,989 $9,170,000 0.3% 0 11.174%
2021-08-13 RP Investment Advisors LP 1,122,836 $10,950,000 1.5% 0 13.348%
2021-08-13 PEAK6 Investments LLC 74,866 $730,000 0.0% 0 0.890%
2021-08-12 DG Capital Management LLC 105,594 $1,030,000 0.2% 0 1.255%
2021-08-12 MMCAP International Inc. SPC 600,000 $5,850,000 0.3% 0 7.133%
2021-08-12 Highbridge Capital Management LLC 1,277,200 $12,450,000 0.3% 0 15.183%
2021-08-12 Athos Capital Ltd 30,000 $290,000 0.1% 0 0.357%
2021-08-11 Picton Mahoney Asset Management 250,000 $2,440,000 0.1% 0 2.972%
2021-08-11 CVI Holdings LLC 400,000 $3,900,000 0.3% 0 4.755%
2021-08-06 Segantii Capital Management Ltd 100,000 $980,000 0.0% 0 1.189%

SEC Filings

Form Type Form Description Filing Date Document Link
10-Q 10-Q 2021-11-22 https://www.sec.gov/Archives/edgar/data/1826435/000114036121038963/brhc10030480_10q.htm
8-K FORM 8-K 2021-11-22 https://www.sec.gov/Archives/edgar/data/1826435/000095010321018223/dp161996_8k.htm
NT 10-Q FORM NT 10-Q 2021-11-15 https://www.sec.gov/Archives/edgar/data/1826435/000095010321017818/dp161758_nt10q.htm
SC 13G SCHEDULE 13G 2021-10-04 https://www.sec.gov/Archives/edgar/data/1826435/000121390021051302/ea148143-13grp_silverspike2.htm
10-Q 10-Q 2021-08-16 https://www.sec.gov/Archives/edgar/data/1826435/000114036121028447/brhc10027792_10q.htm
10-Q 10-Q 2021-06-23 https://www.sec.gov/Archives/edgar/data/1826435/000114036121022027/brhc10025014_10q.htm
8-K 8-K 2021-06-04 https://www.sec.gov/Archives/edgar/data/1826435/000114036121019902/brhc10025388_8k.htm
NT 10-Q FORM NT 10-Q 2021-05-17 https://www.sec.gov/Archives/edgar/data/1826435/000095010321007328/dp151064_nt10q.htm
8-K FORM 8-K 2021-05-03 https://www.sec.gov/Archives/edgar/data/1826435/000095010321006535/dp150335_8k.htm
SC 13G SCHEDULE 13G 2021-03-25 https://www.sec.gov/Archives/edgar/data/1826435/000110465921041497/tm2110943d3_sc13g.htm
8-K FORM 8-K 2021-03-23 https://www.sec.gov/Archives/edgar/data/1826435/000095010321004460/dp148283_8k.htm
SC 13G SC 13G 2021-03-22 https://www.sec.gov/Archives/edgar/data/1826435/000090571821000429/silverspike_13gmar1121.htm
8-K FORM 8-K 2021-03-19 https://www.sec.gov/Archives/edgar/data/1826435/000095010321004309/dp147966_8k.htm
SC 13G SC 13G 2021-03-19 https://www.sec.gov/Archives/edgar/data/1826435/000119312521086682/d24399dsc13g.htm
SC 13G 2021-03-18 https://www.sec.gov/Archives/edgar/data/1826435/000131924421000169/SPKB_SC13G.htm
8-K FORM 8-K 2021-03-15 https://www.sec.gov/Archives/edgar/data/1826435/000095010321004023/dp147727_8k.htm
424B4 FORM 424B4 2021-03-12 https://www.sec.gov/Archives/edgar/data/1826435/000095010321003945/dp147671_424b4.htm
EFFECT 2021-03-10 https://www.sec.gov/Archives/edgar/data/1826435/999999999521000892/xslEFFECTX01/primary_doc.xml
3 2021-03-10 https://www.sec.gov/Archives/edgar/data/1826435/000095010321003796/xslF345X02/dp147606_3-sssiillc.xml
3 FORM 3 2021-03-10 https://www.sec.gov/Archives/edgar/data/1826435/000095010321003795/xslF345X02/dp147535_3-healy.xml
3 FORM 3 2021-03-10 https://www.sec.gov/Archives/edgar/data/1826435/000095010321003793/xslF345X02/dp147534_3-landis.xml
3 FORM 3 2021-03-10 https://www.sec.gov/Archives/edgar/data/1826435/000095010321003792/xslF345X02/dp147533_3-devinsky.xml
3 FORM 3 2021-03-10 https://www.sec.gov/Archives/edgar/data/1826435/000095010321003791/xslF345X02/dp147532_3-goldman.xml
3 FORM 3 2021-03-10 https://www.sec.gov/Archives/edgar/data/1826435/000095010321003789/xslF345X02/dp147531_3-gordon.xml
3 FORM 3 2021-03-10 https://www.sec.gov/Archives/edgar/data/1826435/000095010321003788/xslF345X02/dp147530_3-gentile.xml
CERT 2021-03-10 https://www.sec.gov/Archives/edgar/data/1826435/000135445721000331/8A_Cert_SPKB.pdf
CORRESP 2021-03-09 https://www.sec.gov/Archives/edgar/data/1826435/000095010321003734/filename1.htm
CORRESP 2021-03-09 https://www.sec.gov/Archives/edgar/data/1826435/000095010321003729/filename1.htm
8-A12B FORM 8-A12B 2021-03-09 https://www.sec.gov/Archives/edgar/data/1826435/000095010321003701/dp147299_8a12b.htm
CORRESP 2021-03-05 https://www.sec.gov/Archives/edgar/data/1826435/000095010321003630/filename1.htm
S-1/A FORM S-1/A 2021-03-05 https://www.sec.gov/Archives/edgar/data/1826435/000095010321003629/dp147403_s1a.htm
UPLOAD 2021-03-04 https://www.sec.gov/Archives/edgar/data/1826435/000000000021002610/filename1.pdf
CORRESP 2021-02-08 https://www.sec.gov/Archives/edgar/data/1826435/000095010321001946/filename1.htm
S-1 FORM S-1 2021-02-05 https://www.sec.gov/Archives/edgar/data/1826435/000095010321001895/dp144638_s1.htm
UPLOAD 2020-10-29 https://www.sec.gov/Archives/edgar/data/1826435/000000000020010243/filename1.pdf
DRS 2020-10-01 https://www.sec.gov/Archives/edgar/data/1826435/000095010320019355/filename1.htm